Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCTO.L Regulatory News (CTO)

  • There is currently no data for CTO

Trading Statement

26 Nov 2020 07:00

RNS Number : 5273G
TClarke PLC
26 November 2020
 

 

 

 

TClarke plc

 

TRADING UPDATE

 

ORDER BOOK STRENGTHENS AT TCLARKE AS MARGINS MAINTAINED

 

TClarke plc ("TClarke" or the "Group"), the Building Services Group, today issues a trading update for the period from 1 October 2020 to date.

 

2020 trading update

 

The Group is pleased to report that it continues to trade in line with expectations for the full year ending 31 December 2020. The Board is encouraged by the resilient performance that the Group has delivered.

As stated previously, we anticipate turnover for 2020 to be circa £240m and underlying EBIT (EBIT) to be approximately £6m. TClarke achieved its target 3% EBIT margin in Q1, broke even on much reduced volumes in Q2 and expects to deliver a 3% margin for H2.

During the second half of the year, TClarke has been successful in winning new projects from clients across a wide range of sectors. Our forward order book has increased to £422m. This is a significant result for the Group and is £61m (17%) higher than at the same point in 2019. Reassuringly, revenues of £257m for 2021 have already been secured, against an equivalent figure of £232m at this time last year and up from £191m when we announced the Group's interim results in August. This is testament to our strong reputation among our clients and we have been consistent in maintaining our strict tendering assessments, to ensure that we are accepting work that meets our margin expectations.

 

In addition, TClarke is pleased to be assisting with the rapid delivery of COVID-19 Testing Stations across the UK. New Test Centres are constructed within 24 Hours and our teams across the country are assisting with maintenance of the sites when in use.

 

Outlook

 

TClarke has demonstrated its resilience and agility during 2020. As a Board, we are grateful to all the TClarke team for their hard work and dedication during this challenging period.

 

Looking beyond 2020 our proven strategy remains to focus on projects and markets that meet our margin and growth criteria. The strategy we have followed has resulted in TClarke being particularly strong in the healthcare, education and data centre market sectors, whilst continuing to serve the commercial office market.

 

We have exciting opportunities across all of these market sectors, providing excellent opportunities for growth over the next few years.

 

TClarke approaches the new financial year in a strong position, both operationally and financially.

 

Commenting, Mark Lawrence, TClarke CEO said,

 

" TClarke has once again demonstrated the direct benefits of our excellent reputation within our industry that has helped drive our clients' continued confidence to work with us and award the Group significant new projects.

 

Looking to the future, we have a well-balanced approach to winning work with projects from a range of sectors and I am delighted that we have been so successful in the Healthcare and Technology sectors in particular.

 

The UK Government recently announced a long-term commitment to developing further green initiatives covering clean energy, transport, nature and innovative technologies, that will help the UK to forge ahead with eradicating its contribution to climate change by 2050. TClarke is well positioned to benefit from these initiatives and is already working on a wide range of exciting projects that support these moves."

 

 

Date: 26th November 2020

 

For further information contact:

 

 

TClarke plcMark Lawrence

Group Chief Executive

Trevor Mitchell

Finance Director Tel: 020 7997 7400

www.tclarke.co.uk

 

Cenkos Securities plc (Corporate Broker)

Max Hartley (Corporate Finance)

Nick Searle (Sales)

Tel: 020 7397 8900

www.cenkos.com

 

RMS Partners

Simon Courtenay

Tel: 020 3735 6551

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPGWUGUPUGQA
Date   Source Headline
22nd Jan 20094:31 pmRNSHolding(s) in Company
22nd Jan 20094:26 pmRNSHolding(s) in Company
19th Jan 20094:28 pmRNSDirector/PDMR Shareholding
16th Jan 20093:13 pmRNSReplacement Director/PDMR Shareholding
15th Jan 20094:35 pmRNSHolding(s) in Company
14th Jan 20094:48 pmRNSDirector/PDMR Shareholding
14th Jan 20094:44 pmRNSDirector/PDMR Shareholding
14th Jan 20093:16 pmRNSDirector/PDMR Shareholding
13th Jan 20097:00 amRNSContract Update
16th Dec 20082:01 pmRNSDirector/PDMR Shareholding
24th Nov 20084:40 pmRNSPrice Monitoring Extension
19th Nov 20082:00 pmRNSDirector/PDMR Shareholding
19th Nov 20087:00 amRNSInterim Management Statement
29th Oct 20084:44 pmRNSSecond Price Monitoring Extn
29th Oct 20084:38 pmRNSPrice Monitoring Extension
7th Oct 20084:45 pmRNSSecond Price Monitoring Extn
7th Oct 20084:38 pmRNSPrice Monitoring Extension
1st Oct 20084:32 pmRNSDirector/PDMR Shareholding
17th Sep 20084:44 pmRNSSecond Price Monitoring Extn
17th Sep 20084:38 pmRNSPrice Monitoring Extension
29th Aug 20087:00 amRNSInterim Results
20th Aug 200811:13 amRNSHolding(s) in Company
20th Aug 20087:00 amRNSHolding(s) in Company
31st Jul 20089:35 amRNSDirectorate Change
18th Jul 20087:00 amRNSTrading Statement
7th Jul 20084:32 pmRNSHolding(s) in Company
1st Jul 200812:40 pmRNSNotice of Results
27th Jun 20081:55 pmRNSDirector/PDMR Shareholding
26th Jun 20082:57 pmRNSDirector/PDMR Shareholding
26th Jun 20089:12 amRNSDirector/PDMR Shareholding
19th Jun 20089:09 amRNSDirector/PDMR Shareholding
2nd Jun 20089:26 amRNSAnnual Information Update
23rd May 20084:24 pmRNSHolding(s) in Company
2nd May 20082:00 pmRNSResult of AGM
2nd May 20087:00 amRNSAGM Statement
8th Apr 200811:09 amRNSAnnual Report and Accounts
28th Mar 20087:01 amRNSFinal Results
12th Mar 20089:18 amRNSStmnt re Share Price Movement
12th Feb 20083:05 pmRNSHolding(s) in Company
30th Jan 20089:23 amRNSNotice of Results
9th Jan 200811:21 amRNSDirector/PDMR Shareholding
27th Nov 200710:48 amRNSDirector/PDMR Shareholding
23rd Nov 200712:09 pmRNSDirector/PDMR Shareholding
19th Nov 20077:01 amRNSTrading Statement
13th Nov 20074:22 pmRNSHolding(s) in Company
24th Oct 20079:10 amRNSHolding(s) in Company
3rd Oct 20075:26 pmRNSHolding(s) in Company
14th Sep 200710:09 amRNSHolding(s) in Company
20th Aug 20073:23 pmRNSDirector/PDMR Shareholding
17th Aug 20077:01 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.